DSP Trustee Sells 0.76% Stake in Cohance Lifesciences

DSP Trustee Private Limited, on behalf of various DSP Mutual Fund schemes and DSP Alternative Investment Fund, has disclosed the sale of 28,99,996 shares, representing 0.76% of the total paid-up capital, in Cohance Lifesciences Limited. This transaction resulted in a decrease of their shareholding from approximately 4.29% to 3.53%. The sale occurred on August 7, 2026, and the disclosure is made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as the change exceeded the 2% threshold. DSP Asset Managers Private Limited acts as the investment manager for these funds.